Hypertension, Hyperlipidemia, and Renal Damage

William F. Keane, Bertram L. Kasiske, Michael P. O'Donnell, Youngki Kim

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Experimental studies have demonstrated that a number of factors participate in the progression of renal disease. Systemic and glomerular hypertension have been shown to be critical factors in renal injury. Hyperlipidemia that frequently coexists with renal disease also has been suggested as an important participatory factor in nephron damage. Interestingly, both hypertension and hyperlipidemia seem to evoke glomerular growth, a factor that has also been postulated to be involved in glomerular and tubular destruction. Recently, experimental and clinical data suggest that an important interaction occurs between hyperlipidemia and hypertension. Not only do they frequently coexist, but hypertension dramatically exaggerates hyperlipidemic injury, and hyperlipidemia alters systemic and glomerular vascular production of vasoactive substances which maintain basal vascular tone. Thus, these recent observations underscore the interactive potential of the various risk factors that participate in progression of renal disease. They also suggest that multiple interventional strategies may be needed to optimally prevent progressive nephron loss.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalAmerican Journal of Kidney Diseases
Issue number5
StatePublished - Jan 1 1993


  • Hypertension
  • antilipemic agents
  • glomerulosclerosis
  • hyperlipidemia
  • modified low-density lipoproteins
  • progression

Fingerprint Dive into the research topics of 'Hypertension, Hyperlipidemia, and Renal Damage'. Together they form a unique fingerprint.

Cite this